Urology Clinical Trials in Duarte, CA
As of August 2026, 35 paid clinical trials are recruiting for Urology in Duarte, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
35 clinical trials for Urology
·Clear filters·Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Study With [225Ac]Ac-FL-020 in mCRPC Participants
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Clinical Trial of Approaches to Prostate Cancer Surgery
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)
Telehealth Intervention for Ostomy Self-Management
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Top Research Study Locations in Duarte
Researchers run research studies in Duarte, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| City of Hope Medical Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Myelodysplastic Syndrome | 178 |
| City of Hope | Breast Cancer, Gastric Cancer, Cervical Cancer | 133 |
| City of Hope Comprehensive Cancer Center | Metastatic Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Hematopoietic and Lymphatic System Neoplasm | 84 |
| City of Hope National Medical Center | Breast Cancer, Solid Tumor, Advanced Solid Tumor | 53 |
| City of Hope (City of Hope National Medical Center, City of Hope Medical Center) | Pancreatic Ductal Adenocarcinoma, Acute Myeloid Leukemia, Advanced Breast Cancer | 9 |
| City of Hope Cancer Center | Advanced Solid Tumors, Breast Cancer, Cervical Cancer | 6 |
| City of Hope - Duarte Cancer Center | Advanced Metastatic Castration-resistant Prostate Cancer, Advanced Solid Tumors, Advanced/Metastatic Colorectal Adenocarcinoma | 5 |
| City of Hope - Duarte | Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Anemia, KRAS G12C-mutated Solid Tumors, Lung Cancer | 4 |
| City of Hope Duarte | Multiple Myeloma, Advanced Colorectal Cancer, CRC | 3 |
| City of Hope Cancer Center (Data collection only) | Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 3 |
| Beckman Research Institute of City of Hope | Cancer, End of Life, Prostate Cancer | 2 |
| City of Hope Investigational Drug Services (IDS) | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Urothelial Cancer | 2 |
| City of Hope National Cancer Center | Esophageal Cancer, Gastric Cancer (GC), Gastroesophageal Junction | 2 |
| Dren Investigational Site | Aggressive NK Cell Leukemia, Aplastic Anemias, Bone Marrow Failure Syndromes | 2 |
| IP Address: City of Hope Investigational Drug Services(IDS) | Acute Myeloid Leukemia, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms | 2 |
| Ascentage Investigative | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL | 1 |
| Beckman Research Institute of the City of Hope | Prostate Adenocarcinoma | 1 |
| City Of Hope Comprehensive Cancer Center | Advanced Squamous Tumors | 1 |
| City of Hope - Comprehensive Cancer Center (CCC) | Anemia, Myelodysplastic Syndrome | 1 |
| City of Hope - Duarte Main Site | Mild Thrombocytopenia, Moderate Thrombocytopenia, Myelofibrosis | 1 |
| City of Hope - National Medical Center | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 1 |
| City of Hope -Duarte Cancer Center | Ductal Carcinoma in Situ | 1 |
| City of Hope Blood Donor Center | Anemia, Anemia, Iron Deficiency, IDA - Iron Deficiency Anemia | 1 |
| City of Hope Cancer Center (Data Analysis Only) | Cancer, Recurrence, Recurrent | 1 |
| City of Hope Cancer Center (Data collection AND Specimen Analysis) | Acute Lymphoblastic Leukemia | 1 |
Active & Upcoming Studies in Duarte (2026)
Recruiting trials in Duarte grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (406 active studies)
- Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial · Phase 2 · City of Hope Medical Center
- Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma · Phase 1 · City of Hope Medical Center
Diabetes & metabolic (6 active studies)
- Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes · EARLY_Phase 1 · City of Hope Medical Center
- A Study of GNTI-122 in Adults Recently Diagnosed With T1D · Phase 1 · GentiBio, Inc
Vaccines (3 active studies)
- Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals · Phase 2 · Fred Hutchinson Cancer Center
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study · Phase 3 · Ansun Biopharma, Inc.
HIV / STI (2 active studies)
- Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma · Phase 1 · AIDS Malignancy Consortium
- CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS · EARLY_Phase 1 · City of Hope Medical Center
Neurology & pain (1 active study)
- Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma · University of Southern California
Cardiovascular (1 active study)
Common conditions studied in Duarte
- Acute Myeloid Leukemia (23 active studies)
- Breast Cancer (15 active studies)
- Multiple Myeloma (15 active studies)
- Myelodysplastic Syndrome (14 active studies)
- Ovarian Cancer (14 active studies)
- Malignant Solid Neoplasm (13 active studies)
Leading research sponsors in Duarte
- City of Hope Medical Center
- National Cancer Institute (NCI)
- AstraZeneca
- AbbVie
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Duarte?
There are approximately 543 recruiting clinical trials in Duarte, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Duarte pay participants?
Most recruiting trials in Duarte compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Duarte?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Duarte?
The most common conditions under active study in Duarte include Acute Myeloid Leukemia (23), Breast Cancer (15), Multiple Myeloma (15), Myelodysplastic Syndrome (14), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Duarte?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Duarte on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Duarte?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Duarte?
Recruiting research sites in Duarte include City of Hope Medical Center, City of Hope, City of Hope Comprehensive Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Duarte right now?
The largest active categories in Duarte are Cancer & tumors (406), Diabetes & metabolic (6), Vaccines (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.